Product correctly added to cart.

discount label
3-Bromoisoxazole
View 3D

Biosynth logo

3-Bromoisoxazole

CAS: 111454-71-8

Ref. 3D-FB58284

1gTo inquire
2gTo inquire
5gTo inquire
250mgTo inquire
500mgTo inquire
Estimated delivery in United States, on Friday 17 Jan 2025

Product Information

Name:
3-Bromoisoxazole
Synonyms:
  • Isoxazole, 3-Bromo-
  • Isoxazole, 3-bromo- (9CI)
  • 3-Bromo-1,2-Oxazole
Description:

3-Bromoisoxazole is a nicotinic acetylcholine receptor antagonist that has been shown to reduce blood pressure in rats. It also has neuroprotective effects and inhibits cancer cell proliferation. 3-Bromoisoxazole binds to the estrogen receptor and is a potential treatment for prostate cancer. The molecule also interacts with the urokinase-type plasminogen activator (uPA) and amide receptors, which may be responsible for its antihypertensive effect. The molecular modeling of this compound indicates that it contains an alkynyl group, which may be responsible for its anti-estrogenic activity. 3-Bromoisoxazole is a cholinergic agent that can inhibit cellular proliferation in cancer cells by inducing apoptosis.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
147.96 g/mol
Formula:
C3H2BrNO
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FB58284 3-Bromoisoxazole

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".